Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jk

Journal of Virology

Volumn 88, Issue 12, 2014, Pages 6873-6884

  Zhang, Liming ^a,e   Zhu, Caixia ^a   Guo, Yi ^d   Wei, Fang ^c   Lu, Jie ^b   Qin, Jing ^f   Banerjee, Shuvomoy ^b   Wang, Junwen ^f   Shang, Hong ^d   Verma, Subhash C ^g   Yuan, Zhenghong ^a   Robertson, Erle S ^b   Cai, Qiliang ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d CHINA MEDICAL UNIVERSITY   (China)

^e Central Hospital of Taizhou City   (China)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

^g UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; KAP1 PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; EPISOME; G1 PHASE CELL CYCLE CHECKPOINT; GENETIC ASSOCIATION; GENETIC STABILITY; HERPES VIRUS INFECTION; HUMAN HERPESVIRUS 8; HYPOXIA; INHIBITION KINETICS; LYMPHOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROMOTER REGION; RNA INTERFERENCE; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION;

ANOXIA; CELL CYCLE; CELL LINE, TUMOR; HERPESVIRUS 8, HUMAN; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; OXYGEN; REPRESSOR PROTEINS; SARCOMA, KAPOSI; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84901292002     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00283-14     Document Type: Article

References (56)

1. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d'Agay MF, Clauvel JP, Raphael M, Degos L, Sigaux F. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280.
2. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869. http://dx.doi.org/10.1126/science.7997879.
3. Cai Q, Verma SC, Lu J, Robertson ES. 2010. Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis. Adv. Virus Res. 78:87-142. http://dx.doi.org/10.1016/B978-0-12-385032-4.00003-3.
4. Mesri EA, Cesarman E, BoshoffC. 2010. Kaposi's sarcoma and its associated herpesvirus. Nat. Rev. Cancer 10:707-719. http://dx.doi.org/10.1038/nrc2888.
5. Verma SC, Lan K, Robertson E. 2007. Structure and function of latencyassociated nuclear antigen. Curr. Top. Microbiol. Immunol. 312:101-136.
6. Lukac DM, Renne R, Kirshner JR, Ganem D. 1998. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252:304-312. http://dx.doi.org/10.1006/viro.1998.9486.
7. Nakamura H, Lu M, Gwack Y, Souvlis J, Zeichner SL, Jung JU. 2003. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J. Virol. 77:4205-4220. http://dx.doi.org/10.1128/JVI.77.7.4205-4220.2003.
8. Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, Miller G. 1998. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. U. S. A. 95:10866-10871. http://dx.doi.org/10.1073/pnas.95.18.10866.
9. Xu Y, AuCoin DP, Huete AR, Cei SA, Hanson LJ, Pari GS. 2005. A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication. J. Virol. 79:3479-3487. http://dx.doi.org/10.1128/JVI.79.6.3479-3487.2005.
10. Cai Q, Lan K, Verma SC, Si H, Lin D, Robertson ES. 2006. Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulateRTAexpression during hypoxia: latency control under low oxygen conditions. J. Virol. 80:7965-7975. http://dx.doi.org/10.1128/JVI.00689-06.
11. Davis DA, Rinderknecht AS, Zoeteweij JP, Aoki Y, Read-Connole EL, Tosato G, Blauvelt A, Yarchoan R. 2001. Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood 97:3244-3250. http://dx.doi.org/10.1182/blood. V97.10.3244.
12. Yu Y, Black JB, Goldsmith CS, Browning PJ, Bhalla K, Offermann MK. 1999. Induction of human herpesvirus-8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells. J. Gen. Virol. 80(Part 1):83-90.
13. Iyengar S, Farnham PJ. 2011. KAP1 protein: an enigmatic master regulator of the genome. J. Biol. Chem. 286:26267-26276. http://dx.doi.org/10.1074/jbc. R111.252569.
14. Chang PC, Fitzgerald LD, Van Geelen A, Izumiya Y, Ellison TJ, Wang DH, Ann DK, Luciw PA, Kung HJ. 2009. Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcomaassociated herpesvirus and its modulation by the viral protein kinase. Cancer Res. 69:5681-5689. http://dx.doi.org/10.1158/0008-5472.CAN-08-4570.
15. Le Douarin B, Nielsen AL, Garnier JM, Ichinose H, Jeanmougin F, Losson R, Chambon P. 1996. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J. 15:6701-6715.
16. Friedman JR, Fredericks WJ, Jensen DE, Speicher DW, Huang XP, Neilson EG, Rauscher FJ, III. 1996. KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes Dev. 10:2067-2078. http://dx.doi.org/10.1101/gad.10.16.2067.
17. Ryan RF, Schultz DC, Ayyanathan K, Singh PB, Friedman JR, Fredericks WJ, Rauscher FJ, III. 1999. KAP-1 corepressor protein interacts and colocalizes with heterochromatic and euchromatic HP1 proteins: a potential role for Kruppel-associated box-zinc finger proteins in heterochromatin-mediated gene silencing. Mol. Cell. Biol. 19:4366-4378.
18. Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ, III. 2002. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev. 16:919-932. http://dx.doi.org/10.1101/gad.973302.
19. Yang B, O'Herrin SM, Wu J, Reagan-Shaw S, Ma Y, Bhat KM, Gravekamp C, Setaluri V, Peters N, Hoffmann FM, Peng H, Ivanov AV, Simpson AJ, Longley BJ. 2007. MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res. 67:9954-9962. http://dx.doi.org/10.1158/0008-5472.CAN-07-1478.
20. Ziv Y, Bielopolski D, Galanty Y, Lukas C, Taya Y, Schultz DC, Lukas J, Bekker-Jensen S, Bartek J, Shiloh Y. 2006. Chromatin relaxation in response toDNAdouble-strand breaks is modulated by a novel ATM-and KAP-1 dependent pathway. Nat. Cell Biol. 8:870-876. http://dx.doi.org/10.1038/ncb1446.
21. Li X, Lee YK, Jeng JC, Yen Y, Schultz DC, Shih HM, Ann DK. 2007. Role for KAP1 serine 824 phosphorylation and sumoylation/desumoylation switch in regulating KAP1-mediated transcriptional repression. J. Biol. Chem. 282:36177-36189. http://dx.doi.org/10.1074/jbc.M706912200.
22. Liao G, Huang J, Fixman ED, Hayward SD. 2005. The Epstein-Barr virus replication protein BBLF2/3 provides an origin-tethering function through interaction with the zinc fingerDNAbinding protein ZBRK1 and the KAP-1 corepressor. J. Virol. 79:245-256. http://dx.doi.org/10.1128/JVI.79.1.245-256.2005.
23. Allouch A, Di Primio C, Alpi E, Lusic M, Arosio D, Giacca M, Cereseto A. 2011. The TRIM family protein KAP1 inhibits HIV-1 integration. Cell Host Microbe 9:484-495. http://dx.doi.org/10.1016/j.chom.2011.05.004.
24. Rowe HM, Jakobsson J, Mesnard D, Rougemont J, Reynard S, Aktas T, Maillard PV, Layard-Liesching H, Verp S, Marquis J, Spitz F, Constam DB, Trono D. 2010. KAP1 controls endogenous retroviruses in embryonic stem cells. Nature 463:237-240. http://dx.doi.org/10.1038/nature08674.
25. Wolf D, GoffSP. 2007. TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell 131:46-57. http://dx.doi.org/10.1016/j.cell.2007.07.026.
26. Cai Q, Cai S, Zhu C, Verma SC, Choi J, Robertson ES. 2013. A unique SUMO-2-interacting motif within LANA is essential for KSHV latency. PLoS Pathog. 9:e1003750. http://dx.doi.org/10.1371/journal.ppat.1003750.
27. King CA. 2013. Kaposi's sarcoma-associated herpesvirus kaposin B induces unique monophosphorylation of STAT3 at serine 727 and MK2-mediated inactivation of the STAT3 transcriptional repressor TRIM28. J. Virol. 87:8779-8791. http://dx.doi.org/10.1128/JVI.02976-12.
28. Ma Q, Cavallin LE, Yan B, Zhu S, Duran EM, Wang H, Hale LP, Dong C, Cesarman E, Mesri EA, Goldschmidt-Clermont PJ. 2009. Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proc. Natl. Acad. Sci. U. S. A. 106:8683-8688. http://dx.doi.org/10.1073/pnas.0812688106.
29. Cai Q, Murakami M, Si H, Robertson ES. 2007. A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcomaassociated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia. J. Virol. 81:10413-10423. http://dx.doi.org/10.1128/JVI.00611-07.
30. Carroll PA, Kenerson HL, Yeung RS, LagunoffM. 2006. Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors. J. Virol. 80:10802-10812. http://dx.doi.org/10.1128/JVI.00673-06.
31. Lan K, Kuppers DA, Verma SC, Sharma N, Murakami M, Robertson ES. 2005. Induction of Kaposi's sarcoma-associated herpesvirus latencyassociated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency. J. Virol. 79:7453-7465. http://dx.doi.org/10.1128/JVI.79.12.7453-7465.2005.
32. Cai Q, Verma SC, Kumar P, Ma M, Robertson ES. 2010. Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification. PLoS One 5:e9720. http://dx.doi.org/10.1371/journal.pone.0009720.
33. Si H, Verma SC, Lampson MA, Cai Q, Robertson ES. 2008. Kaposi's sarcoma-associated herpesvirus-encoded LANA can interact with the nuclear mitotic apparatus protein to regulate genome maintenance and segregation. J. Virol. 82:6734-6746. http://dx.doi.org/10.1128/JVI.00342-08.
34. Wei F, Zaprazna K, Wang J, Atchison ML. 2009. PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells. Mol. Cell. Biol. 29:4612-4622. http://dx.doi.org/10.1128/MCB.00234-09.
35. Bai Y, Srinivasan L, Perkins L, Atchison ML. 2005. Protein acetylation regulates both PU.1 transactivation and Ig kappa 3= enhancer activity. J. Immunol. 175:5160-5169.
36. Cai QL, Knight JS, Verma SC, Zald P, Robertson ES. 2006. EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors. PLoS Pathog. 2:e116. http://dx.doi.org/10.1371/journal.ppat.0020116.
37. Lu J, Verma SC, Cai Q, Saha A, Dzeng RK, Robertson ES. 2012. The RBP-Jkappa binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation. PLoS Pathog. 8:e1002479. http://dx.doi.org/10.1371/journal.ppat.1002479.
38. Liang Y, Chang J, Lynch SJ, Lukac DM, Ganem D. 2002. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev. 16:1977-1989. http://dx.doi.org/10.1101/gad.996502.
39. Lan K, Kuppers DA, Robertson ES. 2005. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jα, the major downstream effector of the Notch signaling pathway. J. Virol. 79:3468-3478. http://dx.doi.org/10.1128/JVI.79.6.3468-3478.2005.
40. Tian C, Xing G, Xie P, Lu K, Nie J, Wang J, Li L, Gao M, Zhang L, He F. 2009. KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis. Nat. Cell Biol. 11:580-591. http://dx.doi.org/10.1038/ncb1864.
41. Ganem D. 2006. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu. Rev. Pathol. 1:273-296. http://dx.doi.org/10.1146/annurev.pathol.1.110304.100133.
42. Miller G, Heston L, Grogan E, Gradoville L, Rigsby M, Sun R, Shedd D, Kushnaryov VM, Grossberg S, Chang Y. 1997. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J. Virol. 71:314-324.
43. Veeranna RP, Haque M, Davis DA, Yang M, Yarchoan R. 2012. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors. J. Virol. 86:1097-1108. http://dx.doi.org/10.1128/JVI.05167-11.
44. Haque M, Wang V, Davis DA, Zheng ZM, Yarchoan R. 2006. Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster. J. Virol. 80:7037-7051. http://dx.doi.org/10.1128/JVI.00553-06.
45. Blasius M, Forment JV, Thakkar N, Wagner SA, Choudhary C, Jackson SP. 2011. A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1. Genome Biol. 12:R78. http://dx.doi.org/10.1186/gb-2011-12-8-r78.
46. Greer SN, Metcalf JL, Wang Y, Ohh M. 2012. The updated biology of hypoxia-inducible factor. EMBO J. 31:2448-2460. http://dx.doi.org/10.1038/emboj.2012.125.
47. Tanigaki K, Honjo T. 2010. Two opposing roles of RBP-J. in Notch signaling. Curr. Top. Dev. Biol. 92:231-252. http://dx.doi.org/10.1016/S0070-2153(10)92007-3.
48. Scholz BA, Harth-Hertle ML, Malterer G, Haas J, Ellwart J, Schulz TF, Kempkes B. 2013. Abortive lytic reactivation of KSHV in CBF1/CSL deficient human B cell lines. PLoS Pathog. 9:e1003336. http://dx.doi.org/10.1371/journal.ppat.1003336.
49. Chen J, Ye F, Xie J, Kuhne K, Gao SJ. 2009. Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA. Virology 386:290-302. http://dx.doi.org/10.1016/j.virol.2009.01.031.
50. Paulose-Murphy M, Ha NK, Xiang C, Chen Y, Gillim L, Yarchoan R, Meltzer P, Bittner M, Trent J, Zeichner S. 2001. Transcription program of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J. Virol. 75:4843-4853. http://dx.doi.org/10.1128/JVI.75.10.4843-4853.2001.
51. Jenner RG, Alba MM, BoshoffC, Kellam P. 2001. Kaposi's sarcomaassociated herpesvirus latent and lytic gene expression as revealed byDNA arrays. J. Virol. 75:891-902. http://dx.doi.org/10.1128/JVI.75.2.891-902.2001.
52. Persson LM, Wilson AC. 2010. Wide-scale use of Notch signaling factor CSL/RBP-Jkappa in RTA-mediated activation of Kaposi's sarcomaassociated herpesvirus lytic genes. J. Virol. 84:1334-1347. http://dx.doi.org/10.1128/JVI.01301-09.
53. Liu Y, Cao Y, Liang D, Gao Y, Xia T, Robertson ES, Lan K. 2008. Kaposi's sarcoma-associated herpesvirus RTA activates the processivity factor ORF59 through interaction with RBP-Jkappa and a cis-acting RTA responsive element. Virology 380:264-275. http://dx.doi.org/10.1016/j.virol.2008.08.011.
54. Lendahl U, Lee KL, Yang H, Poellinger L. 2009. Generating specificity and diversity in the transcriptional response to hypoxia. Nat. Rev. Genet. 10:821-832. http://dx.doi.org/10.1038/nrg2665.
55. Chen J, Imanaka N, Griffin JD. 2010. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br. J. Cancer 102:351-360. http://dx.doi.org/10.1038/sj.bjc.6605486.
56. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, Ruas JL, Poellinger L, Lendahl U, Bondesson M. 2005. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev. Cell 9:617-628. http://dx.doi.org/10.1016/j.devcel.2005.09.010.